BFRI Stock Summary and Trading Ideas (Biofrontera | NASDAQ:BFRI)

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

Biofrontera trades on the NASDAQ stock market under the symbol BFRI.

As of January 31, 2025, BFRI stock price climbed to $1.07 with 9,884 million shares trading.

BFRI has a beta of -1.25, meaning it tends to be less sensitive to market movements. BFRI has a correlation of 0.02 to the broad based SPY ETF.

BFRI has a market cap of $9.50 million. This is considered a Sub-Micro Cap stock.

Last quarter Biofrontera reported $9 million in Revenue and -$.98 earnings per share. This fell short of revenue expectation by $-998,000 and missed earnings estimates by -$.15.

In the last 3 years, BFRI traded as high as $122.40 and as low as $.61.

The top ETF exchange traded funds that BFRI belongs to (by Net Assets): VXF.

BFRI has underperformed the market in the last year with a price return of -21.3% while the SPY ETF gained +25.5%. However, in the short term, BFRI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +14.6% vs +5.4% return in SPY. But in the last 2 weeks, BFRI shares have been beat by the market, returning 0.0% compared to an SPY return of +3.0%.

BFRI support price is $.99 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BFRI shares will trade within this expected range on the day.